Specific changes of serum proteins in Parkinson's disease patients

20Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

The aim of this study is to identify and validate protein change in the serum from PD patients. We used serum samples from 21 PD patients and 20 age-matched normal people as control to conduct a comparative proteomic study. We performed 2-DE and analyzed the differentially expressed protein spots by LC-MS/MS. In PD group 13 spots were shown to be differentially expressed compared to control group. They were identified as 6 proteins. Among these, 3 proteins were confirmed by Western blot analysis. It showed that the frequency of fibrinogen γ-chain (FGG) appeared 70% in PD, which could not be detected in control group. The protein of inter-alpha-trypsin inhibitor heavy chain H4 (ITI-H4) was found to exist two forms in serum. The full size (120 kDa) of the protein was increased and the fragmented ITI-H4 (35 kDa) was decreased in PD group. The ratio of full size ITI-H4 to fragmented ITI-H4 in PD patients was 3.85±0.29-fold higher than in control group. Furthermore, fragmented Apo A-IV (∼26 kDa) was mainly detected in control group, while it was rare to be found in PD group. Above findings might be useful for diagnosis of PD. When the expressions of FGG and 120 kDa ITI-H4 are increase, as well as ∼26 kDa Apo A-IV disappear would provide strong evidence for PD. © 2014 Lu et al.

Figures

  • Figure 2. Representative silver-stained 2-DE gels of serum proteins from controls (A) and PD patients (B). The most dominant proteins in human sera derived from controls and PD patients were depleted by an immunoaffinity column (MARS) and then separated by 2-DE. Molecular weight is indicated on the left side in kDa. doi:10.1371/journal.pone.0095684.g002
  • Figure 3. Distribution of differentially expressed protein spots.
  • Figure 1. Serum depletion. It was clear from 2-DE of whole serum and depleted serum proteins that many more proteins were visible in the depleted sample (B) than were in the whole serum sample (A) when both gels were loaded with the same overall amount of serum proteins. doi:10.1371/journal.pone.0095684.g001
  • Figure 4. Expanded images of protein spots differentially expressed between PD patients and controls. The protein FGG (spot 390, 213, 214 and 209) and haptoglobin (spot 14) were increased in abundance in the serum from PD patients, relative to the levels in controls, whereas the levels of prothrombin (spot 429 and 277), interalpha-trypsin inhibitor heavy chain H4 (spot 422 and 393), apolipoprotein A-I (spot 278 and 41) and apolipoprotein A-IV (spot 268 and 266) were decreased in PD serum relative to the levels in controls. doi:10.1371/journal.pone.0095684.g004
  • Table 1. Variation ratios of the protein spots differentially expressed in the serum from PD patients versus controls.
  • Figure 5. Representative results of the identification of protein (FGG) by LC-MS/MS. (A) Chromatogram of peptide mixture. (B and C) MS/ MS spectra of two peptides. doi:10.1371/journal.pone.0095684.g005
  • Table 3. Identified peptides for each differentially expressed protein (spot) analyzed by LC-MS/MS.
  • Figure 6. Expression of FGG, Apo A-IV, and ITI-H4 in individual depleted serum samples from 4 PD patients and 4 control subjects. (A) Representative panel of Western blots. It shows that full size (46 kDa) and ,26 kDa fragment of Apo A-IV and full size (120 kDa) and 35 kDa fragment of ITI-H4 existed in PD and control serum. (B) Quantitative comparison of the Western blot shown in (A). FGG was only detected in PD serum samples. The level of full size Apo A-IV was increased, whereas fragmented Apo A-IV was decreased in PD patients compared with controls. The level of full size ITI-H4 was increased, whereas fragmented ITI-H4 was decreased in PD patients compared with controls. Total protein concentration in each sample was determined by Bradford assay. Protein loadings were approximately equal for all samples (20 mg/lane). Data represent mean 6 S.E.M. for 4 individual subjects per group. *, p,0.05 compared with control, Student’s t-test. doi:10.1371/journal.pone.0095684.g006

References Powered by Scopus

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinico-pathological study of 100 cases

9319Citations
N/AReaders
Get full text

Statistical significance for genomewide studies

7737Citations
N/AReaders
Get full text

Mutation in the α-synuclein gene identified in families with Parkinson's disease

7268Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The role of lipids in Parkinson’s disease

172Citations
N/AReaders
Get full text

Pituitary adenylate cyclase-activating polypeptide (PACAP) has a neuroprotective function in dopamine-based neurodegeneration in rat and snail parkinsonian models

62Citations
N/AReaders
Get full text

Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease

44Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lu, W., Wan, X., Liu, B., Rong, X., Zhu, L., Li, P., … Wang, X. (2014). Specific changes of serum proteins in Parkinson’s disease patients. PLoS ONE, 9(4). https://doi.org/10.1371/journal.pone.0095684

Readers over time

‘14‘15‘16‘17‘18‘19‘20‘21‘22‘230481216

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 13

65%

Researcher 3

15%

Professor / Associate Prof. 2

10%

Lecturer / Post doc 2

10%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 6

38%

Medicine and Dentistry 4

25%

Pharmacology, Toxicology and Pharmaceut... 3

19%

Biochemistry, Genetics and Molecular Bi... 3

19%

Save time finding and organizing research with Mendeley

Sign up for free
0